| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | 0.095 | 0.01 |
| mRNA | HG-5-88-01 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.01 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | -0.08 | 0.01 |
| mRNA | BRD8958 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.01 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | -0.16 | 0.01 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | 0.3 | 0.01 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.02 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | 0.092 | 0.02 |
| mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.02 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.085 | 0.02 |